Biotech entity
pharma is the sole category represented across all 1 tracked stories. Superstring Capital Management LP is most often covered alongside Citadel Advisors LLC, which appears in 1 of these 1 story. Superstring Capital Management LP appears in 1 tracked Biotech story from August 12, 2026.
Last mentioned: Aug 12, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Superstring Capital Management LP is most often covered alongside Citadel Advisors LLC, which appears in 1 of these 1 story. Superstring Capital Management LP appears in 1 tracked Biotech story from August 12, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 11 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Superstring Capital Management LP. Shared-story counts are live from our verified record — not editorial picks.
Shares of Entera Bio slipped 0.6% to $1.54 on 78% below-average volume, but analysts remain deeply split: HC Wainwright reiterates buy while Weiss Ratings maintains a sell. The $9.00 consensus target implies roughly 484% upside for the $75.91M microcap biotech.
Source: dailypolitical.com · tickerreport.com
Superstring Capital Management LP is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
